Co-stimulatory blockade with belatacept in kidney transplantation

Long-Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys

(2013) B. Charpentier et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study

(2013) L. Rostaing et al.   AMERICAN JOURNAL OF TRANSPLANTATION

T-cell co-stimulatory blockade in transplantation: two steps forward one step back!

(2013) Leonardo V Riella et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study

(2012) K. Budde et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Belatacept: a new biological agent for maintenance immunosuppression in kidney transplantation

(2012) Swati Arora et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

(2011) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients

(2011) S. M. Flechner et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Logistics and Strategy of Multiorgan Procurement Involving Total Face Allograft

(2011) J. Bueno et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Belatacept-versus Cyclosporine-Based Immunosuppression in Renal Transplant Recipients with Pre-existing Diabetes

(2011) L. Rostaing et al.   Clinical Journal of the American Society of Nephrology

Use of 12-Month Renal Function and Baseline Clinical Factors to Predict Long-Term Graft Survival

(2011) Mark A. Schnitzler et al.   TRANSPLANTATION

Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients

(2010) R. Ferguson et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)

(2010) A. Durrbach et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

(2010) K. E. Lamb et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients: A Randomized Phase II Study

(2010) L. Rostaing et al.   Clinical Journal of the American Society of Nephrology